Arun K. Garg - Autologous Blood Concentrates

113. Randelli PS, Arrigoni P, Cabitza P, Volpi P, Maffulli N. Autologous platelet rich plasma for arthroscopic rotator cuff repair. A pilot study. Disabil Rehabil 2008;30:1584–1589.

114. Chahal J, Van Thiel GS, Mall N, et al. The role of platelet-rich plasma in arthroscopic rotator cuff repair: A systematic review with quantitative synthesis. Arthroscopy 2012;28:1718–1727.

115. Charousset C, Zaoui A, Bellaïche L, Piterman M. Does autologous leukocyte-platelet-rich plasma improve tendon healing in arthroscopic repair of large or massive rotator cuff tears? Arthroscopy 2014;30:428–435.

116. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90:133–146.

117. Kirsner RS, Warriner R, Michela M, Stasik L, Freeman K. Advanced biological therapies for diabetic foot ulcers. Arch Dermatol 2010;146:857–862.

118. Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: Topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg 2014;40:152–161 [erratum 2014;40:601].

119. Assenza M, Valesini L, Monacelli G, et al. Traumatic complex wounds, multidisciplinary approach: Our experience in a case series. Clin Ter 2010;161:e95–e99.

120. Serra R, Buffone G, Dominijanni A, Molinari V, Montemurro R, de Franciscis S. Application of platelet-rich gel to enhance healing of transmetatarsal amputations in diabetic dysvascular patients. Int Wound J 2013;10:612–615.

121. Yamada T, Onishi K, Utsunomiya M, Nakamura M. Our treatment strategy for critical limb ischemia. Int J Vasc Med 2013;2013:437471.

122. Toscano N, Holtzclaw D. Surgical considerations in the use of platelet-rich plasma. Compend Contin Educ Dent 2008;29:182–185.

123. Smith SE, Roukis TS. Bone and wound healing augmentation with platelet-rich plasma. Clin Podiatr Med Surg 2009;26:559–588.

124. Maney P, Amornporncharoen M, Palaiologou A. Applications of plasma rich in growth factors (PRGF) in dental surgery: A review. J West Soc Periodontol Periodontal Abstr 2013;61:99–104.

125. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone 1999;25(2 suppl):47S–50S.

126. Jenis LG, Banco RJ, Kwon B. A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J 2006;6:14–20.

127. Dimar JR 2nd, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 2009;91:1377–1386.

128. Zhang H, Wang F, Ding L, et al. A meta-analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft. PLoS One 2014;9:e97049.

129. Kitoh H, Kitakoji T, Tsuchiya H, Katoh M, Ishiguro N. Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma. J Pediatr Orthop 2007;27:629–634.

130. Kitoh H, Kawasumi M, Kaneko H, Ishiguro N. Differential effects of culture-expanded bone marrow cells on the regeneration of bone between the femoral and the tibial lengthenings. J Pediatr Orthop 2009;29:643–649.

131. Kim SJ, Pierce W, Sabharwal S. The etiology of short stature affects the clinical outcome of lower limb lengthening using external fixation. A systematic review of 18 trials involving 547 patients. Acta Orthop 2014;85:181–186.

132. Weibrich G, Kleis WK, Hitzler WE, Hafner G. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: A technical report. Int J Oral Maxillofac Implants 2005;20:118–123.

133. Gandhi A, Bibbo C, Pinzur M, Lin SS. The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 2005;10:621–637.

134. Bibbo C, Hatfield PS. Platelet-rich plasma concentrate to augment bone fusion. Foot Ankle Clin 2010;15:641–649.

135. Bielecki T, Gazdzik TS, Szczepanski T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 2008;40:289–296.

136. Nathan ST, Fisher BE, Roberts CS, Giannoudis PV. The management of nonunion and delayed union of patella fractures: A systematic review of the literature. Int Orthop 2011;35:791–795.

137. Del Corso M, Vervelle A, Simonpieri A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: Periodontal and dentoalveolar surgery. Curr Pharm Biotechnol 2012;13:1207–1230.

138. Simonpieri A, Del Corso M, Vervelle A, et al. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery. Curr Pharm Biotechnol 2012;13:1231–1256.

139. Roffi A, Filardo G, Kon E, Marcacci M. Does PRP enhance bone integration with grafts, graft substitutes, or implants? A systematic review. BMC Musculoskelet Disord 2013;14:330.

140. Georgakopoulos I, Tsantis S, Georgakopoulos P, et al. The impact of platelet rich plasma (PRP) in osseointegration of oral implants in dental panoramic radiography: Texture based evaluation. Clin Cases Miner Bone Metab 2014;11:59–66.

141. Davis VL, Abukabda AB, Radio NM, et al. Platelet-rich preparations to improve healing. Part I: Workable options for every size practice. J Oral Implantol 2014;40:500–510.

142. Schwartz-Arad D, Ofec R, Eliyahu G, Ruban A, Sterer N. Long-term follow-up of dental implants placed in autologous onlay bone graft. Clin Implant Dent Relat Res 2016;18:449–461.

143. Ntounis A, Geurs N, Vassilopoulos P, Reddy M. Clinical assessment of bone quality of human extraction sockets after conversion with growth factors. Int J Oral Maxillofac Implants 2015;30:196–201.

144. Grant WP, Jerlin EA, Pietrzak WS, Tam HS. The utilization of autologous growth factors for the facilitation of fusion in complex neuropathic fractures in the diabetic population. Clin Podiatr Med Surg 2005;22:561–584.

145. Sood A, Cunningham C, Lin S. The BB Wistar rat as a diabetic model for fracture healing. ISRN Endocrinol 2013;2013:349604.

146. Chahla J, Cimque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasmapreparation protocols and composition reporting. A systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am 2017;99:1769–1779.

147. Mautner K, Malanga GA, Smith J, et al. A call for a standard classification system for future biologic research: The rationale for new PRP nomenclature. Phys Med Rehabil 2015;7(4 suppl):S53–S59.

148. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158–167.

149. Marx RE. Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent 2001;10:225–228.

150. Rughetti A, Giusti I, D’Ascenzo S, et al. Platelet gel-released supernatant modulates the angiogenic capability of human endothelial cells. Blood Transfus 2008;6:12–17.

151. Dhurat R, Sukesh M. Principles and methods of preparation of platelet-rich plasma: A review and author’s perspective. J Cutan Aesthet Surg 2014;7:189–197.

152. Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008;84:415–421.

153. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am 2012;94:308–316.